Delivery Order SPE2DB25D3001-SPE2DB25FQVKD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,837.30 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract. This award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,137.72 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement supporting federal pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $76,814.55 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 24, 2025, and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $13,322.71 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on August 6, 2025, with completion expected by August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,217.49 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against an existing indefinite delivery contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $5,737.25 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its critical role in the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $11,428.25 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count unit of use packaging) on August 29, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction for federal medical procurement. The work will be performed at AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $10,970.04 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive set-aside contract. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $2,477.39 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on August 1, 2025, with completion targeted for August 4, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) valued at $3,868.52 under a firm fixed-price contract type. This is a non-set-aside competitive award issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment of this pharmaceutical product delivery. This delivery order represents a child contract...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQVKDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $72,465.26 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location, leveraging its established position as a critical vendor within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 value through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's demonstrated capability to compete successfully for federal pharmaceutical contracts across multiple therapeutic domains reflects its significance within the Defense Logistics Agency's medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $72.5k | 9/24/25 |